Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11724580rdf:typepubmed:Citationlld:pubmed
pubmed-article:11724580lifeskim:mentionsumls-concept:C0212694lld:lifeskim
pubmed-article:11724580lifeskim:mentionsumls-concept:C0012860lld:lifeskim
pubmed-article:11724580lifeskim:mentionsumls-concept:C0165675lld:lifeskim
pubmed-article:11724580lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:11724580lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:11724580lifeskim:mentionsumls-concept:C1511692lld:lifeskim
pubmed-article:11724580lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:11724580lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:11724580lifeskim:mentionsumls-concept:C0054362lld:lifeskim
pubmed-article:11724580pubmed:issue48lld:pubmed
pubmed-article:11724580pubmed:dateCreated2001-11-28lld:pubmed
pubmed-article:11724580pubmed:abstractTextTreatment of cells with the enediyne C-1027 is highly efficient at inducing single- and double-strand DNA breaks. This agent is highly cytotoxic when used at picomolar levels over a period of days. For this study, C-1027 has been used at higher levels for a much shorter time period to look at early cellular responses to DNA strand breaks. Extracts from cells treated with C-1027 for as little as 2 h are deficient in SV40 DNA replication activity. Treatment with low levels of C-1027 (1-3 nM) does not result in the presence of a replication inhibitor in cell extracts, but they are deficient in replication protein A (RPA) function. Extracts from cells treated with high levels of C-1027 (10 nM) do show the presence of a trans-acting inhibitor of DNA replication. The deficiency in RPA in extracts from cells treated with low levels of C-1027 can be fully complemented by the addition of exogenous RPA, and may be due to a C-1027-induced decrease in the extractability of RPA. This decrease in the extractability of RPA correlates with the appearance of many extraction-resistant intranuclear RPA foci. The trans-acting inhibitor of DNA replication induced by treatment of cells with high levels of C-1027 (10 nM) is DNA-dependent protein kinase (DNA-PK). DNA-PK is activated by the presence of DNA fragments induced by C-1027 treatment, and can be abrogated by removal of the DNA fragments. Although it is activated by DNA damage and phosphorylates RPA, DNA-PK is not required for either RPA focalization or loss of RPA replication activity.lld:pubmed
pubmed-article:11724580pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:languageenglld:pubmed
pubmed-article:11724580pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:citationSubsetIMlld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11724580pubmed:statusMEDLINElld:pubmed
pubmed-article:11724580pubmed:monthDeclld:pubmed
pubmed-article:11724580pubmed:issn0006-2960lld:pubmed
pubmed-article:11724580pubmed:authorpubmed-author:BeermanT ATAlld:pubmed
pubmed-article:11724580pubmed:authorpubmed-author:LimJ KJKlld:pubmed
pubmed-article:11724580pubmed:authorpubmed-author:HoY HYHlld:pubmed
pubmed-article:11724580pubmed:authorpubmed-author:KwaS BSBlld:pubmed
pubmed-article:11724580pubmed:authorpubmed-author:MelendyTTlld:pubmed
pubmed-article:11724580pubmed:issnTypePrintlld:pubmed
pubmed-article:11724580pubmed:day4lld:pubmed
pubmed-article:11724580pubmed:volume40lld:pubmed
pubmed-article:11724580pubmed:ownerNLMlld:pubmed
pubmed-article:11724580pubmed:authorsCompleteYlld:pubmed
pubmed-article:11724580pubmed:pagination14661-8lld:pubmed
pubmed-article:11724580pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:meshHeadingpubmed-meshheading:11724580...lld:pubmed
pubmed-article:11724580pubmed:year2001lld:pubmed
pubmed-article:11724580pubmed:articleTitleDNA damage by the enediyne C-1027 results in the inhibition of DNA replication by loss of replication protein A function and activation of DNA-dependent protein kinase.lld:pubmed
pubmed-article:11724580pubmed:affiliationDepartment of Microbiology & Biochemistry, State University of New York at Buffalo, School of Medicine & Biomedical Sciences, Buffalo, New York 14214, USA.lld:pubmed
pubmed-article:11724580pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11724580pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11724580pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:11724580pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11724580lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11724580lld:pubmed